Trust Co. of Toledo NA OH Reduces Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Trust Co. of Toledo NA OH lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 21.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,575 shares of the company's stock after selling 712 shares during the period. Trust Co. of Toledo NA OH's holdings in HCA Healthcare were worth $890,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $28,000. Whipplewood Advisors LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth $31,000. Tidemark LLC purchased a new stake in HCA Healthcare during the fourth quarter worth about $36,000. Legacy Investment Solutions LLC grew its position in shares of HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares during the period. Finally, MV Capital Management Inc. raised its holdings in shares of HCA Healthcare by 31.8% in the 1st quarter. MV Capital Management Inc. now owns 199 shares of the company's stock worth $69,000 after purchasing an additional 48 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of NYSE HCA traded up $3.50 during mid-day trading on Tuesday, reaching $372.09. 1,334,129 shares of the company were exchanged, compared to its average volume of 1,457,072. The stock has a market capitalization of $89.51 billion, a PE ratio of 15.87, a PEG ratio of 1.27 and a beta of 1.49. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company's 50 day moving average price is $359.19 and its 200 day moving average price is $333.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company's revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the company earned $5.36 EPS. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.77%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's dividend payout ratio is presently 12.81%.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.30% of the company's stock.

Analyst Ratings Changes

HCA has been the subject of a number of recent research reports. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an "equal weight" rating in a research report on Monday, June 9th. Wells Fargo & Company upgraded HCA Healthcare from an "underweight" rating to an "equal weight" rating and lifted their price target for the company from $320.00 to $385.00 in a research report on Thursday, May 29th. Finally, Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $392.47.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.